Moderna's two-in-one flu and Covid vaccine passes advanced trial

Drug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a single shot, has passed a vital part of final-stage scientific checks.And it does so as effectively as separate flu and Covid shots, results suggest.Chief executive Stephane Bancel told BBC News he hoped the messenger ribonucleic acid vaccine could be made widely available in 2026 - or perhaps, 2025.

"We are very delighted about the results, because it’s the first time in the world that a company is able to show positive phase-three results combining in a single dose flu and Covid vaccine," he said.Competitors Pfizer and BioNTech are testing a similar two-in-one mRNA vaccine against flu and Covid.It matched or bettered currently approved flu jabs, including high-dose ones designed for older people.

And it was better than Moderna’s existing Covid booster, Spikevax, at making the body produce disease-fighting antibodies – probably because it had been designed to fight more recent variants circulating around the world, Mr Bancel told BBC News in an interview.Moderna said it had focused on older people because they were most likely to continue to be offered Covid vaccines.

The company plans to present the findings at a medical conference, as well as submit them for publication.Veteran finishes Everest marathon in citrus outfitFarmers to drive length of British coastline in JCB

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trialModerna is the first company to release positive phase three data on a Covid and flu combination shot, giving it a lead over rivals Pfizer and Novavax. 
Source: NBCNewYork - 🏆 270. / 63 Read more »

Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trialModerna is the first company to release positive phase three data on a Covid and flu combination shot, giving it a lead over rivals Pfizer and Novavax.
Source: CNBC - 🏆 12. / 72 Read more »

Covid-flu combination vaccine shows positive results in late-stage trial, Moderna saysThere could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this year’s flu season.
Source: cnnbrk - 🏆 393. / 55 Read more »

Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Source: ForbesTech - 🏆 318. / 59 Read more »